Literature DB >> 9371909

Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.

J H Bower1, D M Maraganore, S K McDonnell, W A Rocca.   

Abstract

Information on the incidence of progressive supranuclear palsy (PSP) is limited; incidence rates for multiple system atrophy (MSA) are not available. We studied the incidence of PSP and MSA in Olmsted County, Minnesota, for the years 1976 to 1990. This study was part of a larger investigation of all forms of parkinsonism. We used the medical records-linkage system of the Rochester Epidemiology Project to identify all subjects whose records contained documentation of any from of parkinsonism, related neurodegenerative diseases, or tremor of any type. A nurse abstractor screened the records and, when applicable, a neurologist reviewed them to determine the presence or absence of parkinsonism. Cases of parkinsonism were classified using specified diagnostic criteria. Population denominators were derived from census data and were corrected by removing prevalent cases of parkinsonism. Over the 15 years of the study, we found 16 incident cases of PSP and nine incident cases of MSA. No cases of PSP or MSA had onset before age 50 years. The average annual incidence rate (new cases per 100,000 person-years) for ages 50 to 99 years was 5.3 for PSP and 3.0 for MSA. The incidence of PSP increased steeply with age from 1.7 at 50 to 59 years to 14.7 at 80 to 99 years, and was consistently higher in men. Median survival time from symptom onset was 5.3 years for PSP and 8.5 years for MSA. The incidence of PSP increases with age and is consistently higher in men at all ages. PSP and MSA are more common than previously recognized.

Entities:  

Mesh:

Year:  1997        PMID: 9371909     DOI: 10.1212/wnl.49.5.1284

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  78 in total

Review 1.  Progressive supranuclear palsy.

Authors:  H U Rehman
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

Review 2.  Progressive supranuclear palsy (Steele-Richardson-Olszewski disease).

Authors:  H R Morris; N W Wood; A J Lees
Journal:  Postgrad Med J       Date:  1999-10       Impact factor: 2.401

Review 3.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems.

Authors:  Allison W Willis; Bradley A Evanoff; Min Lian; Aiden Galarza; Andrew Wegrzyn; Mario Schootman; Brad A Racette
Journal:  Am J Epidemiol       Date:  2010-10-19       Impact factor: 4.897

Review 5.  Orthostatic hypotension: managing a difficult problem.

Authors:  Pearl K Jones; Brett H Shaw; Satish R Raj
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-01

Review 6.  Epidemiological evidence on multiple system atrophy.

Authors:  N Vanacore
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

Review 7.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 8.  Other dementias.

Authors:  Gaida Krumina
Journal:  Neuroradiology       Date:  2011-09       Impact factor: 2.804

Review 9.  Recognizing Atypical Parkinsonisms: "Red Flags" and Therapeutic Approaches.

Authors:  Nikolaus R McFarland; Christopher W Hess
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

10.  Relative mortality in U.S. Medicare beneficiaries with Parkinson disease and hip and pelvic fractures.

Authors:  Marcie Harris-Hayes; Allison W Willis; Sandra E Klein; Sylvia Czuppon; Beth Crowner; Brad A Racette
Journal:  J Bone Joint Surg Am       Date:  2014-02-19       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.